Efavirenz/lamivudine/tenofovir disoproxil fumarateElevation in AST: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1746卷 / 1期

关键词：

D O I：

10.1007/s40278-019-59529-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[1] Efavirenz/lamivudine/tenofovir disoproxil fumarateVarious toxicities: case report
[J]. Reactions Weekly, 2016, 1630 (1) : 94 - 94
[2] Efavirenz/lamivudine/tenofovir disoproxil fumarateRenal tubular acidosis: case report
[J]. Reactions Weekly, 2023, 1958 (1) : 205 - 205
[3] Tenofovir-disoproxil-fumarateElevation in ALP: case report
[J]. Reactions Weekly, 2020, 1814 (1) : 325 - 325
[4] Efavirenz/lamivudine/tenofovir-disoproxil-fumarateRetroviral rebound syndrome: case report
[J]. Reactions Weekly, 2021, 1859 (1) : 152 - 152
[5] Efavirenz/lamivudine/tenofovir-disoproxil-fumarateImmune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2023, 1948 (1) : 178 - 178
[6] Efavirenz/lamivudine/tenofovir-disoproxil-fumarateDevelopment of resistance and skin allergy: case report
[J]. Reactions Weekly, 2021, 1841 (1) : 103 - 103
[7] Efavirenz/lamivudine/tenofovir-disoproxil-fumarateHypothyroidism
[J]. Reactions Weekly, 2024, 2005 (1) : 345 - 345
[8] Dolutegravir/lamivudine/tenofovir/efavirenz/lamivudine/tenofovirInadvertent administration of dolutegravir/lamivudine/tenofovir, resistance to dolutegravir/lamivudine/tenofovir and efavirenz/lamivudine/tenofovir : case report
[J]. Reactions Weekly, 2019, 1734 (1) : 187 - 187
[9] Dolutegravir/lamivudine/tenofovir-disoproxil-fumarate/Efavirenz/lamivudine/tenofovir-disoproxil-fumarateFanconi syndrome
[J]. Reactions Weekly, 2024, 2013 (1) : 167 - 167
[10] Efavirenz/lamivudine/tenofovir disoproxil fumarateVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2019, 1783 (1) : 113 - 113

← 1 2 3 4 5 →